China Shineway Pharmaceutical Group Limited
CSWYY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,145,721 | $1,240,253 | $722,773 | $556,674 |
| Dep. & Amort. | $68,735 | $177,102 | $185,862 | $182,386 |
| Deferred Tax | $0 | $0 | $0 | $207,064 |
| Stock-Based Comp. | $0 | $0 | $0 | $34 |
| Change in WC | $221,959 | -$93,616 | -$228,410 | -$207,098 |
| Other Non-Cash | -$473,280 | -$391,104 | $429,451 | -$35,910 |
| Operating Cash Flow | $963,135 | $932,635 | $1,109,676 | $703,150 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$140,112 | -$144,325 | -$129,463 | -$93,633 |
| Net Acquisitions | $2,335 | $0 | $920 | $9,389 |
| Inv. Purchases | -$844,997 | -$520,000 | -$320,230 | -$370,000 |
| Inv. Sales/Matur. | $527,613 | $530,536 | $306,668 | $379,073 |
| Other Inv. Act. | $183,051 | $84,249 | $96,685 | $470,182 |
| Investing Cash Flow | -$272,110 | -$49,540 | -$45,420 | $395,011 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $30,000 | $300,000 | $0 | -$369,319 |
| Stock Issued | $0 | $0 | $0 | $3,663 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$407,916 | -$317,268 | -$241,728 | -$453,072 |
| Other Fin. Act. | -$14,559 | -$9,470 | -$8,310 | -$10,207 |
| Financing Cash Flow | -$392,475 | -$26,738 | -$250,038 | -$828,935 |
| Forex Effect | -$47,173 | $6,154 | $6,325 | -$6,514 |
| Net Chg. in Cash | $251,377 | $862,511 | $820,543 | $262,712 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,888,776 | $5,026,265 | $4,205,722 | $3,943,010 |
| End Cash | $6,140,153 | $5,888,776 | $5,026,265 | $4,205,722 |
| Free Cash Flow | $823,023 | $788,310 | $980,213 | $609,517 |